3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Fatty Liver
1
Burkitt Lymphoma
1
Interventions
Exercise
24
Metformin
23
Resistance Training
8
Nutrition Assessment
8
Methods
8
Tirzepatide
7
Diet Therapy
7
Diet
7
Counseling
7
Early Intervention, Educational
6
Caloric Restriction
6
Exenatide
5
semaglutide
4
Liraglutide
4
Educational Status
4
Docosahexaenoic Acids
4
Diet, Mediterranean
4
Vitamin D
3
Therapeutics
3
Surveys and Questionnaires
3
Sugars
3
Standard of Care
3
Dexamethasone
3
Yoga
2
Tablets
2
Specimen Handling
2
Progestins
2
Ovidrel
2
Nutritional Status
2
Naltrexone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Obesity
×
penclomedine
×
Clear all
NCT02157974
2024-06-04
APPLE
University of Colorado, Denver
Phase 2/3
Completed
92 enrolled
17 charts